But it comes with an important caveat that every patient deserves to understand: as of this writing, the FDA has not yet published its formal updated list
Ensure Safety and Integration: Help you navigate information and ensure any considerations for BPC-157 fit safely within your existing health regimen and medications
Athletes subject to drug testing should avoid AOD9604, as its use could trigger a positive result and lead to suspensions or disqualifications
It also means cagrilintide could potentially be an option for people who dont respond well to GLP-1-based medications, or who experience side effects that make GLP-1 drugs hard to tolerate
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide a chain of 15 amino acids derived from a naturally occurring protein found in human gastric juice
It is important to note that most side effects are mild, transient, and resolve with continued use or dosage adjustment